Liaison Tech partners with SAFE-BioPharma Association

Monday, February 13, 2012 03:06 PM

Liaison Technologies, a global provider of secure cloud-based integration and data management services, has partnered with the SAFE-BioPharma Association.

Through the partnership, Liaison’s clients and their partners can leverage the validation and security of the SAFE-BioPharma standard, which verifies and manages digital identities and signatures involved in electronic transactions.

“Liaison’s enablement of the SAFE-BioPharma standard in a cloud-based platform is important to life sciences organizations as they utilize this important technology,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. 

The standard was designed to speed transformation of the biopharmaceutical and healthcare communities to a fully digital environment, while mitigating legal, regulatory and other business risks associated with electronic transactions. Recognized by the DEA and in line with HIPAA regulations, the standard provides a way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions.

“Collaborating with SAFE-BioPharma shows an ongoing commitment to ensuring our cloud-based services are supported by industry standards that enhance the quality and security of patient and other sensitive data,” said Gary Palgon, Liaison’s vice president of healthcare solutions.

Earlier this year, Liaison announced a healthcare partner program in an effort to expand services available to clients so they can more easily exchange information in light of the HITECH Act and new models of care.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 22

DaVita combines its two research CRO units to create an end-to-end CRO focused on kidney, end-stage renal disease

New crop of clinical trial matching services use patient’s molecular, genomic data for better fit

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs